These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1576677)

  • 21. Influence of thromboxane A2 inhibition on the development of hydronephrotic atrophy.
    Huland H; Brenger B; Gonnermann D; Schäfer H
    Urol Int; 1986; 41(6):422-5. PubMed ID: 3824698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and dipeptidyl peptidase inhibition of N-(4-substituted-2,4-diaminobutanoyl)piperidines.
    Soroka A; Van der Veken P; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4777-9. PubMed ID: 16844373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors.
    Zhu X; Sheth KA; Li S; Chang HH; Fan JQ
    Angew Chem Int Ed Engl; 2005 Dec; 44(45):7450-3. PubMed ID: 16231389
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity.
    Christoff JJ; Bradley L; Miller DD; Lei L; Rodriguez F; Fraundorfer P; Romstedt K; Shams G; Feller DR
    J Med Chem; 1997 Jan; 40(1):85-91. PubMed ID: 9016331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on psychotropic agents. V. Synthesis of 1-substituted spiro[dibenz[b,f]oxepin-11,4'-piperidine]-10(11H)-one and related compounds.
    Nagai Y; Uno H
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2056-64. PubMed ID: 519807
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonsteroidal antiinflammatory agents. III. Synthesis of the metabolites of 10,11-dihydro-8, alpha-dimethyl-11-oxodibenz-[b,f]oxepin-2-acetic acid (bermoprofen).
    Hino K; Nakamura H; Kato S; Irie A; Nagai Y; Uno H
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3462-7. PubMed ID: 3240540
    [No Abstract]   [Full Text] [Related]  

  • 28. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
    Reynolds EE; Mok LL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):915-21. PubMed ID: 2138670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel 7-oxabicyclo[2.2.1]-heptane thromboxane A2 derivatives containing substitution on positions one and two.
    Kan WM; Yek YL
    Adv Exp Med Biol; 1997; 407():497-501. PubMed ID: 9321997
    [No Abstract]   [Full Text] [Related]  

  • 31. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
    Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.
    Guth BD; Narjes H; Schubert HD; Tanswell P; Riedel A; Nehmiz G
    Br J Clin Pharmacol; 2004 Jul; 58(1):40-51. PubMed ID: 15206991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-dependent contraction induced by substance P in canine cerebral arteries: involvement of NK1 receptors and thromboxane A2.
    Shirahase H; Murase K; Kanda M; Kurahashi K; Nakamura S
    Life Sci; 1999; 64(3):211-9. PubMed ID: 10027752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic role of thromboxane A2 in immediate food hypersensitivity reactions in children.
    Ohtsuka T; Matsumaru S; Uchida K; Onobori M; Matsumoto T; Kuwahata K; Arita M
    Ann Allergy Asthma Immunol; 1996 Jul; 77(1):55-9. PubMed ID: 8705637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategy for the enantioselective synthesis of trans-2,4-disubstituted piperidines: application to the CCR3 antagonist IS811.
    Kauffman GS; Watson PS; Nugent WA
    J Org Chem; 2006 Nov; 71(23):8975-7. PubMed ID: 17081035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
    Pierucci A; Simonetti BM; Pecci G; Mavrikakis G; Feriozzi S; Cinotti GA; Patrignani P; Ciabattoni G; Patrono C
    N Engl J Med; 1989 Feb; 320(7):421-5. PubMed ID: 2643773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids.
    Lagarde M; Boutillon MM; Guichardant M; Lellouche JP; Beaucourt JP; Vanhove A; Grée R
    Biochem Pharmacol; 1989 Jun; 38(11):1863-4. PubMed ID: 2735941
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Blondin C; Cholley B; Haeffner-Cavaillon N; Goldschmidt P
    J Fr Ophtalmol; 2003 Apr; 26(4):328-36. PubMed ID: 12843888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myotropic activity of leukotriene B4 on lung parenchyma strips is not necessarily attributable to thromboxane A2 release.
    Fitzpatrick FA; Lawson CF
    J Pharmacol Exp Ther; 1988 Jun; 245(3):839-44. PubMed ID: 2838607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.